Barclays’s Cellebrite CLBT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.24M | Sell |
140,037
-13,987
| -9% | -$224K | ﹤0.01% | 2150 |
|
|
2025
Q1 | $2.99M | Sell |
154,024
-291,771
| -65% | -$5.67M | ﹤0.01% | 1765 |
|
|
2024
Q4 | $9.82M | Buy |
445,795
+182,138
| +69% | +$4.01M | ﹤0.01% | 1141 |
|
|
2024
Q3 | $4.44M | Buy |
263,657
+59,395
| +29% | +$1,000K | ﹤0.01% | 1614 |
|
|
2024
Q2 | $2.44M | Sell |
204,262
-99,740
| -33% | -$1.19M | ﹤0.01% | 1576 |
|
|
2024
Q1 | $3.37M | Buy |
304,002
+212,779
| +233% | +$2.36M | ﹤0.01% | 1583 |
|
|
2023
Q4 | $790K | Buy |
91,223
+75,615
| +484% | +$655K | ﹤0.01% | 2762 |
|
|
2023
Q3 | $119K | Buy |
15,608
+1,982
| +15% | +$15.1K | ﹤0.01% | 3261 |
|
|
2023
Q2 | $98K | Buy |
+13,626
| New | +$98K | ﹤0.01% | 3410 |
|